HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
Abstract To evaluate the feasibility of serum HMGB1, anti-HMGB1 antibodies, and HMGB1/anti-HMGB1 ratio as a diagnosis indicator of initial clinical classification in patients with fever of unknown origin (FUO). Ninety-four patients with classical FUO and ninety healthy controls were enrolled in this...
Guardado en:
Autores principales: | Mingkun Chen, Li Zhu, Miao Xue, Rongrong Zhu, Liling Jing, Huaizhou Wang, Yanghua Qin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a0959dbf066424b91e100631227e561 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
por: Li Fu, et al.
Publicado: (2017) -
Indirect regulation of HMGB1 release by gasdermin D
por: Allen Volchuk, et al.
Publicado: (2020) -
Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting
por: Lu Li, et al.
Publicado: (2021) -
Subcellular localization of HMGB1 in human cholangiocarcinoma: correlation with tumor stage
por: Nattawan Suwannakul, et al.
Publicado: (2021) -
HMGB1 mediates endogenous TLR2 activation and brain tumor regression.
por: James F Curtin, et al.
Publicado: (2009)